This pathbreaking rare disease diagnostics business had been and was now looking to accelerate sales. Of primary importance was unlocking untapped adoption potential with genetic counselors and pediatric neurologists.
We engaged clinicians and key decision-makers, and in one month validated the top barriers in both the purchase journey and product experience. Through rapid, iterative testing solutions were identified and implemented in the short term for the purchase journey and medium term for minor product modifications. Sales accelerated in month one, growing to serve over 200 diagnostic cases per week in one hospital alone.